Compare ADMA Biologics Inc (ADMA) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Gigacloud Technology Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Gigacloud Technology Inc trades at $51 (market cap $1.84B). The key difference: ADMA Biologics Inc is the larger of the two by market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | GCT | |
|---|---|---|
Market Cap | $2.22B | $1.84B |
Sector | Health | Technology |
52-Week High | $20.38 | $53.25 |
52-Week Low | $7.60 | $25.44 |
Enterprise Value | $2.29B | $1.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
